Please Wait
Applying Filters...

Information, Expiry & Status of Health Canada Patents covering Aprovel.

Menu
$ API Ref.Price (USD/KG) : 175Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 6Sanofi-Aventis Canada Inc.

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
AAPS 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Patent Expiration Date : 2011-03-20

Date Granted : 1997-07-08

Irbesartan

Brand Name : AVAPRO

Patent Number : 2057913

Filing Date : 1991-03-20

Strength per Unit : 75mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2011-03-20

Date Granted : 1997-07-08

Sanofi Company Banner

02

arrow
AAPS 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Patent Expiration Date : 2011-03-20

Date Granted : 1997-07-08

Irbesartan

Brand Name : AVAPRO

Patent Number : 2057913

Filing Date : 1991-03-20

Strength per Unit : 150mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2011-03-20

Date Granted : 1997-07-08

Sanofi Company Banner

03

arrow
AAPS 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Patent Expiration Date : 2011-03-20

Date Granted : 1997-07-08

Irbesartan

Brand Name : AVAPRO

Patent Number : 2057913

Filing Date : 1991-03-20

Strength per Unit : 300mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2011-03-20

Date Granted : 1997-07-08

Sanofi Company Banner

04

arrow
AAPS 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Patent Expiration Date : 2016-05-30

Date Granted : 2007-04-10

Irbesartan

Brand Name : AVAPRO

Patent Number : 2177772

Filing Date : 1996-05-30

Strength per Unit : 75mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2016-05-30

Date Granted : 2007-04-10

Sanofi Company Banner

05

arrow
AAPS 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Patent Expiration Date : 2016-05-30

Date Granted : 2007-04-10

Irbesartan

Brand Name : AVAPRO

Patent Number : 2177772

Filing Date : 1996-05-30

Strength per Unit : 150mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2016-05-30

Date Granted : 2007-04-10

Sanofi Company Banner

06

arrow
AAPS 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Patent Expiration Date : 2016-05-30

Date Granted : 2007-04-10

Irbesartan

Brand Name : AVAPRO

Patent Number : 2177772

Filing Date : 1996-05-30

Strength per Unit : 300mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2016-05-30

Date Granted : 2007-04-10

Sanofi Company Banner